← Evidence map

Observational studyDrugs in R&D2019

S-1 in Patients with Advanced Esophagogastric Adenocarcinoma: Results from the Safety Compliance Observatory on Oral fluoroPyrimidines (SCOOP) Study.

Marino VeneritoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

S-1 in Patients with Advanced Esophagogastric Adenocarcinoma: Results from the Safety Compliance Observatory on Oral fluoroPyrimidines (SCOOP) Study. | OpenQuestion